AdvaMed 2015: Innovation Spotlight On Diabetes, Heart Failure Start-Ups
Medtech start-ups continue to bring fresh ideas and new approaches to a market that is continually looking for better and cheaper treatment options. The device industry’s major trade association recently featured dozens of start-ups at its annual conference, and companies offering new solutions to battle chronic diseases were among the highlights.
You may also be interested in...
The focus of the diabetes market is firmly on the development of an artificial pancreas, now within two or three years from becoming commercialized, and progress is going so well that several companies are in line to release a product. Meanwhile, digital health is increasingly playing a major role in diabetes care, and device manufacturers are investing in connectivity solutions to satisfy patient and consumer needs.
Delegates at the European Health Forum Gastein outlined the challenges facing an international effort to improve access to costly new medicines across the World Health Organization’s European region, insisting that the key issues had to be addressed “collectively” and without “finger pointing.”
In this week's podcast edition of Five Must-Know Things: landmark results for lecanemab in Alzheimer’s; other Alzheimer’s players rise after the lecanemab results; Leqvio’s importance to Novartis; Pfizer’s secret sauce for digitalization; and Amgen’s clinical trial diversity efforts.